Glenmark Pharmaceuticals Limited — Others, 01-07-2025: Shareholders meeting

Glenmark Pharmaceuticals has announced a postal ballot seeking shareholder approval for the appointment of Mr. Anurag Mantri as Executive Director and Global Chief Financial Officer for five years starting May 27, 2025. Mr. Mantri, a Chartered Accountant with over 30 years of leadership experience across Indian and global firms, joined Glenmark as President – Finance in April 2025. His annual remuneration includes a salary of INR 1.68 Cr, personal pay of INR 2.58 Cr, and long-term incentives starting at INR 1 Cr for FY26, increasing annually subject to performance. This strategic hire aims to strengthen Glenmark’s financial leadership. Electronic voting is enabled for shareholders.